by EmpathiCSubstanceS | Aug 16, 2022 | Psychedelic Research
Administration of 5-MeO-DMT occasioned strong mystical experiences (MEQ30 Overall Mintensity = 4.17, ± 0.64, range 0–5) and the majority (75%) had “a complete mystical experience” (≥60% on all MEQ30 subscales). Compared to a prior laboratory-based psilocybin study,...
by EmpathiCSubstanceS | Aug 16, 2022 | Psychedelic Research
Compared with placebo, DMT markedly reduced oscillatory power in the alpha and beta bands and robustly increased spontaneous signal diversity. Time-referenced and neurophenomenological analyses revealed close relationships between changes in various aspects of...
by EmpathiCSubstanceS | Aug 12, 2022 | Bipolar Disorder, Chronic Pain, Kambo, LSD, MDMA Sassafras Molly, Microdosing, NN-Dimethyltryptamine, OCD, Psilocybin Magic Mushroom, Psychedelic Medicine
COULD AN OVERACTIVE IMMUNE SYSTEM make you depressed? In the late 1990s, psychiatrist Andrew Miller and his colleagues began to notice that patients with cancer, cardiovascular disease, obesity and Crohn’s disease—all conditions that cause higher than normal levels of...
by EmpathiCSubstanceS | Aug 12, 2022 | Anxiety, Ayahuasca, Microdosing, NN-Dimethyltryptamine, OCD, Pain, Psilocybin Magic Mushroom, Psychedelic Medicine
THE EXAMINATION ROOMS IN THE BLUESTON CENTER FOR CLINICAL RESEARCH at the New York University College of Dentistry are exactly what you might expect of a facility that conducts trials of dental and medical therapies. There are reclining exam chairs, linoleum floors,...
by EmpathiCSubstanceS | Aug 12, 2022 | Ayahuasca, Bipolar Disorder, Depression, DMT, Iboga, Kambo, LSD, MDMA Sassafras Molly, NN-Dimethyltryptamine, OCD, Psychedelic Medicine, PTSD
During his decades as Massachusetts General Hospital’s Chief of Psychiatry, Jerry Rosenbaum observed that patients suffering from a range of mental illnesses would sometimes get stuck in a state of rumination, or unceasing cycles of unpleasant, self-deprecating...
